Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 18035697)

1.

[Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in MedB-1 mediastinal lymphoma line].

Barth TF, Melzner I, Wegener S, Bucur AJ, Brüderlein S, Dorsch K, Hasel C, Leithäuser F, Möller P.

Verh Dtsch Ges Pathol. 2005;89:234-44. German.

PMID:
18035697
2.

Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line.

Melzner I, Bucur AJ, Brüderlein S, Dorsch K, Hasel C, Barth TF, Leithäuser F, Möller P.

Blood. 2005 Mar 15;105(6):2535-42. Epub 2004 Nov 30.

3.

Biallelic deletion within 16p13.13 including SOCS-1 in Karpas1106P mediastinal B-cell lymphoma line is associated with delayed degradation of JAK2 protein.

Melzner I, Weniger MA, Bucur AJ, Brüderlein S, Dorsch K, Hasel C, Leithäuser F, Ritz O, Dyer MJ, Barth TF, Möller P.

Int J Cancer. 2006 Apr 15;118(8):1941-4.

PMID:
16287070
4.

Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation.

Weniger MA, Melzner I, Menz CK, Wegener S, Bucur AJ, Dorsch K, Mattfeldt T, Barth TF, Möller P.

Oncogene. 2006 Apr 27;25(18):2679-84.

PMID:
16532038
5.

Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-cell lymphoma allows prediction of therapeutic targets.

Raia V, Schilling M, Böhm M, Hahn B, Kowarsch A, Raue A, Sticht C, Bohl S, Saile M, Möller P, Gretz N, Timmer J, Theis F, Lehmann WD, Lichter P, Klingmüller U.

Cancer Res. 2011 Feb 1;71(3):693-704. doi: 10.1158/0008-5472.CAN-10-2987. Epub 2010 Dec 2.

6.

[Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation].

Weniger MA, Melzner I, Menz CK, Wegener S, Bucur AJ, Dorsch K, Mattfeldt T, Barth TF, Möller P.

Verh Dtsch Ges Pathol. 2006;90:210-5. German.

PMID:
17867599
7.

Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.

Guiter C, Dusanter-Fourt I, Copie-Bergman C, Boulland ML, Le Gouvello S, Gaulard P, Leroy K, Castellano F.

Blood. 2004 Jul 15;104(2):543-9. Epub 2004 Mar 25.

9.

Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.

Malpeli G, Barbi S, Moore PS, Scardoni M, Chilosi M, Scarpa A, Menestrina F.

Haematologica. 2004 Sep;89(9):1091-9.

10.

Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line.

Ritz O, Leithäuser F, Hasel C, Brüderlein S, Ushmorov A, Möller P, Wirth T.

J Pathol. 2005 Feb;205(3):336-48.

PMID:
15682441
11.
12.

Pathobiology of primary mediastinal B-cell lymphoma.

Pileri SA, Zinzani PL, Gaidano G, Falini B, Gaulard P, Zucca E, Sabattini E, Ascani S, Rossi M, Cavalli F; International Extranodal Lymphoma Study Group.

Leuk Lymphoma. 2003;44 Suppl 3:S21-6. Review.

PMID:
15202521
13.

SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor.

Ali S, Nouhi Z, Chughtai N, Ali S.

J Biol Chem. 2003 Dec 26;278(52):52021-31. Epub 2003 Oct 1.

14.

The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2.

Kamizono S, Hanada T, Yasukawa H, Minoguchi S, Kato R, Minoguchi M, Hattori K, Hatakeyama S, Yada M, Morita S, Kitamura T, Kato H, Nakayama Ki, Yoshimura A.

J Biol Chem. 2001 Apr 20;276(16):12530-8. Epub 2001 Jan 19.

15.

Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma.

Copie-Bergman C, Boulland ML, Dehoulle C, Möller P, Farcet JP, Dyer MJ, Haioun C, Roméo PH, Gaulard P, Leroy K.

Blood. 2003 Apr 1;101(7):2756-61. Epub 2002 Nov 21.

16.

SOCS-mediated downregulation of mutant Jak2 (V617F, T875N and K539L) counteracts cytokine-independent signaling.

Haan S, Wüller S, Kaczor J, Rolvering C, Nöcker T, Behrmann I, Haan C.

Oncogene. 2009 Aug 27;28(34):3069-80. doi: 10.1038/onc.2009.155. Epub 2009 Jun 22.

PMID:
19543316
17.

Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.

Ritz O, Guiter C, Castellano F, Dorsch K, Melzner J, Jais JP, Dubois G, Gaulard P, Möller P, Leroy K.

Blood. 2009 Aug 6;114(6):1236-42. doi: 10.1182/blood-2009-03-209759. Epub 2009 May 7.

18.

Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function.

Flowers LO, Johnson HM, Mujtaba MG, Ellis MR, Haider SM, Subramaniam PS.

J Immunol. 2004 Jun 15;172(12):7510-8.

19.

Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6.

Mottok A, Renné C, Willenbrock K, Hansmann ML, Bräuninger A.

Blood. 2007 Nov 1;110(9):3387-90. Epub 2007 Jul 25.

20.

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

Green MR, Monti S, Rodig SJ, Juszczynski P, Currie T, O'Donnell E, Chapuy B, Takeyama K, Neuberg D, Golub TR, Kutok JL, Shipp MA.

Blood. 2010 Oct 28;116(17):3268-77. doi: 10.1182/blood-2010-05-282780. Epub 2010 Jul 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk